Nanobody immunology expert Jo Van Ginderachter joins Xi’an Jiaotong University.

The ceremony for appointing Professor Jo Van Ginderachter, a professor from the Free University of Brussels and an expert in tumor microenvironment immune regulation, as a visiting professor at Xi'an Jiaotong University was held in the lecture hall of the Medical Department's Nursing Building. Professor Serge Muyldermans, the founder of Belgian nanobody technology, Professor Zhang Baogen from the Basic Medical College, Professor Wen Yurong from the Intensive Care Department of the First Affiliated Hospital, Dr. Wu Shuang from the PET/CT Center, Dr. Zhang Mingru from the Imaging Department of Xijing Hospital, as well as representatives from the teachers and students of the Basic Medical College and the First Affiliated Hospital attended the appointment ceremony. 
In his speech, Professor Zheng Fang warmly congratulated Professor Van Ginderachter on his appointment as a visiting professor at Xi'an Jiaotong University. He also introduced his significant contributions in the field of tumor immune microenvironment research and the application of nanobodies. Professor Zhang Baogen from the School of Basic Medicine of Xi'an Jiaotong University presented the visiting professor certificate to Professor Van Ginderachter and had him wear the university badge.

Van GinderachterThe professor gave a lecture titled“Nanobody-based modulation and imaging of immunosuppressive cells in the tumor microenvironment”(A Report on the Regulation and Imaging of Immune Suppressive Cells in Tumor Microenvironment Based on Nanobodies). He systematically introduced the situation of his team's research on the heterogeneity and functions of immune regulatory cells such as monocytes, macrophages, dendritic cells and regulatory T cells in the tumor microenvironment using nanobody technology, as well as the development of corresponding diagnostic and therapeutic strategies.

Professor Jo Van Ginderachter is a world-renowned expert in tumor immunology. He serves as the director and full-time professor of the Immunology Center at VUB University, and as the director of the Immunology Center of the Flemish National Institute of Life Sciences. Professor Van Ginderachter has been dedicated to fundamental and translational research on the tumor immune microenvironment for a long time. He also serves as the president of the Belgian Society for Immunology, the president of the Belgian Cancer Research Association, and a board member of the Flemish Vaccine Company. The team has achieved international-leading research levels in immune regulation and molecular imaging, and possesses strong academic strength and rich technical reserves in the fields of cell and molecular immune mechanisms, dynamic detection of immune cell subgroups, and the development of targeted immunotherapy. They have published 157 academic papers, with a total citation count exceeding 23,671, and an H-index of 62. Professor Van Ginderachter has 6 patent series groups, covering innovative drugs in fields such as tumor immunology and infectious disease vaccines.